Citi Upgrades Emerson (EMR) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts EMR Hot Sheet
Price: $161.59 +0.81%
Rating Summary:
27 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
27 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
Citi upgraded Emerson (NYSE: EMR) from Neutral to Buy.
For an analyst ratings summary and ratings history on Emerson click here.For more ratings news on Emerson click here.
Shares of Emerson closed at $50.89 yesterday.
For an analyst ratings summary and ratings history on Emerson click here.For more ratings news on Emerson click here.
Shares of Emerson closed at $50.89 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Goldman Sachs (GS) to Buy
- Emerson (EMR) PT Raised to $145 at Morgan Stanley
- Emkay Global Upgrades CYIENT (CYL:IN) to Add (2)
Create E-mail Alert Related Categories
UpgradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
